SWK Holdings
  • Home
  • About SWK
    • People
    • Board of Directors
  • Our Approach
    • Investment Process
    • Investment Criteria
    • Creative Capital Solutions
    • Partner with SWK
  • Portfolio
  • Investor Relations
    • Overview
    • News Releases
    • Events & Presentations
    • Stock Information
    • Financial Information
    • Corporate Governance
    • Investor Resources
    • Enteris Biopharma
  • Enteris Biopharma
  • Contact Us
Select Page

SWK Holdings Corporation Announces Closing of an Up to $30 Million Debt Financing

by admin | Sep 9, 2013 | 2013, News

Raises Ownership Limit for Carlson Capital, L.P. DALLAS, Sept. 9, 2013 (GLOBE NEWSWIRE) — SWK Holdings Corporation (SWKH) (“SWK” or the “Company”), a life science focused specialty finance company, announced today that it has closed a credit facility of up to $30...

SWK Holdings Corporation Announces the 2013 Annual Shareholders Meeting Will Be Held on September 18, 2013

by admin | Aug 1, 2013 | 2013, News

Dallas, TX, August 1, 2013 – SWK Holdings Corporation (“SWK” or the “Company”) (SWKH:OB) today announced that it has set Wednesday, September 18, 2013, as the date of its 2013 Annual Meeting of Stockholders (the “Annual Meeting”), and that the record date...

Year

  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012

© 2019 SWK Holdings. All Rights Reserved.

SWK Holdings Corporation

14755 Preston Road, Suite 105
Dallas, TX 75254
Phone: 972.687.7250
Fax: 972.687.7255

For Investors:
investorrelations@swkhold.com

For Capital Alternatives:
inquiries@swkhold.com

For Career Opportunities:
recruiting@swkhold.com